Therefore, MOXD1 knockdown affected the function of EGFR, which may also be the reason why the brain of mice injected with shMOXD1 GBM cells was significantly smaller than that of mice injected with shGFP GBM cells. The gene discussed is EGFR; the disease is glioblastoma.